Ocuphire Pharma (OCUP) stock forecast for 2024. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Ocuphire Pharma (OCUP) stock forecast for 2024

Updated: March 28, 2024 (07:53)

Sector: Healthcare

The share price of Ocuphire Pharma, Inc. (OCUP) now

What analysts predict: $19.2
52-week High/Low: $6.6 / $1.85

50/200 Day Moving Average: $2.454 / $3.245

This figure corresponds to the Average Price over the previous 50/200 days. For Ocuphire Pharma stocks, the 50-day moving average is the resistance level today.

For Ocuphire Pharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Ocuphire Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ocuphire Pharma stock price in 2024. How much will one Ocuphire Pharma share be worth in 2024? Is it worth taking profit / loss on OCUP stock now or waiting? What are analysts' forecasts for Ocuphire Pharma stock?

We forecast Ocuphire Pharma stock performance using neural networks based on historical data on OCUP stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Ocuphire Pharma, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Ocuphire Pharma analysts is $19.2. Today 200 Day Moving Average is the resistance level (3.245 $). 50 Day Moving Average is the resistance level (2.454 $).




Historical and forecast chart of Ocuphire Pharma, Inc. stock

The chart below shows the historical price of Ocuphire Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OCUP stock price can be found in the table below.


Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.

Ocuphire Pharma (OCUP) Forecast for 2024

Month Target Pes. Opt. Vol., %
Apr 2.03 1.71 2.38 28.24 %
May 2.08 1.83 2.29 19.95 %
Jun 2.02 1.75 2.21 20.78 %
Jul 1.58 1.27 1.83 30.67 %
Aug 1.28 1.15 1.49 23.06 %
Sep 1.47 1.33 1.58 15.78 %
Oct 1.78 1.64 2.06 20.35 %
Nov 1.97 1.60 2.36 32.29 %
Dec 1.94 1.58 2.25 29.96 %

Ocuphire Pharma information and performance

Ocuphire Pharma Address

15245 SHADY GROVE ROAD, SUITE 455, ROCKVILLE, MD, US

Market Capitalization: 49 999 000 $

Market capitalization of the Ocuphire Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of OCUP shares in the company outstanding by the market price of one share.

EBITDA: -10 557 000 $

EBITDA of Ocuphire Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.46

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.958
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 12.0

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.599

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.056

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 24813400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Ocuphire Pharma price target for 2024 by month


Target values for the price of one Ocuphire Pharma share for Apr 2024.

The weighted average target price per Ocuphire Pharma share in Apr 2024 is: 2.03.
In Apr, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 28.238% volatility is expected.
Pessimistic target level: 1.71
Optimistic target level: 2.38

Target values for the price of one Ocuphire Pharma share for May 2024.

The weighted average target price per Ocuphire Pharma share in May 2024 is: 2.08.
In May, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 19.955% volatility is expected.
Pessimistic target level: 1.83
Optimistic target level: 2.29

Target values for the price of one Ocuphire Pharma share for Jun 2024.

The weighted average target price per Ocuphire Pharma share in Jun 2024 is: 2.02.
In Jun, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 20.776% volatility is expected.
Pessimistic target level: 1.75
Optimistic target level: 2.21

Target values for the price of one Ocuphire Pharma share for Jul 2024.

The weighted average target price per Ocuphire Pharma share in Jul 2024 is: 1.58.
In Jul, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 30.670% volatility is expected.
Pessimistic target level: 1.27
Optimistic target level: 1.83

Target values for the price of one Ocuphire Pharma share for Aug 2024.

The weighted average target price per Ocuphire Pharma share in Aug 2024 is: 1.28.
In Aug, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 23.061% volatility is expected.
Pessimistic target level: 1.15
Optimistic target level: 1.49

Target values for the price of one Ocuphire Pharma share for Sep 2024.

The weighted average target price per Ocuphire Pharma share in Sep 2024 is: 1.47.
In Sep, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 15.777% volatility is expected.
Pessimistic target level: 1.33
Optimistic target level: 1.58

Target values for the price of one Ocuphire Pharma share for Oct 2024.

The weighted average target price per Ocuphire Pharma share in Oct 2024 is: 1.78.
In Oct, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 20.347% volatility is expected.
Pessimistic target level: 1.64
Optimistic target level: 2.06

Target values for the price of one Ocuphire Pharma share for Nov 2024.

The weighted average target price per Ocuphire Pharma share in Nov 2024 is: 1.97.
In Nov, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 32.292% volatility is expected.
Pessimistic target level: 1.60
Optimistic target level: 2.36

Target values for the price of one Ocuphire Pharma share for Dec 2024.

The weighted average target price per Ocuphire Pharma share in Dec 2024 is: 1.94.
In Dec, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 29.957% volatility is expected.
Pessimistic target level: 1.58
Optimistic target level: 2.25



Ocuphire Pharma (OCUP) stock dividend

Ocuphire Pharma last paid dividends on 01/01/1970. The next scheduled payment will be on 11/06/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.